Cas no 225923-23-9 ((1S)-1-(2,6-dichlorophenyl)ethan-1-ol)
(1S)-1-(2,6-dichlorophenyl)ethan-1-ol Chemical and Physical Properties
Names and Identifiers
-
- (S)-1-(2,6-Dichloro-phenyl)-ethanol
- 8393AH
- (1S)-1-(2,6-Dichlorophenyl)ethanol
- SB35598
- (S)-1-(2,6-Dichlorophenyl)ethan-1-ol
- (S)-alpha-Methyl-2,6-dichlorobenzenemethanol
- (1S)-1-(2,6-dichlorophenyl)ethan-1-ol
-
- MDL: MFCD22570014
- Inchi: 1S/C8H8Cl2O/c1-5(11)8-6(9)3-2-4-7(8)10/h2-5,11H,1H3/t5-/m0/s1
- InChI Key: VUSOJMQVQGKPNN-YFKPBYRVSA-N
- SMILES: ClC1C=CC=C(C=1[C@H](C)O)Cl
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 119
- XLogP3: 2.7
- Topological Polar Surface Area: 20.2
(1S)-1-(2,6-dichlorophenyl)ethan-1-ol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-1g |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 1g |
10854.94CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-5g |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 5g |
39688.38CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-500mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 500mg |
5851.49CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-100mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 100mg |
2111.63CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-250mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 250mg |
3349.77CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 03R0320-50mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 96% | 50mg |
1484.07CNY | 2021-05-07 | |
| eNovation Chemicals LLC | Y1127628-100mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 95% | 100mg |
$455 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1127628-250mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 95% | 250mg |
$665 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1127628-500mg |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 95% | 500mg |
$985 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1127628-1g |
(S)-1-(2,6-Dichloro-phenyl)-ethanol |
225923-23-9 | 95% | 1g |
$1430 | 2024-07-28 |
(1S)-1-(2,6-dichlorophenyl)ethan-1-ol Related Literature
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
Additional information on (1S)-1-(2,6-dichlorophenyl)ethan-1-ol
Introduction to (1S)-1-(2,6-dichlorophenyl)ethan-1-ol and Its Significance in Modern Chemical Research
(1S)-1-(2,6-dichlorophenyl)ethan-1-ol, with the CAS number 225923-23-9, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This chiral alcohol, characterized by its (1S) configuration and a phenyl ring substituted with two chlorine atoms at the 2 and 6 positions, has garnered attention due to its versatile applications in the development of novel therapeutic agents and mechanistic studies.
The structural motif of (1S)-1-(2,6-dichlorophenyl)ethan-1-ol combines the electron-withdrawing effect of the chloro substituents with the lipophilic nature of the aromatic ring, making it a valuable building block in medicinal chemistry. The stereochemistry introduced by the (1S) configuration is particularly crucial, as it can influence the binding affinity and selectivity of potential drug candidates.
In recent years, there has been a growing emphasis on the development of enantioselective synthetic methodologies to access chiral compounds like (1S)-1-(2,6-dichlorophenyl)ethan-1-ol. Advanced catalytic systems, including transition metal-catalyzed asymmetric reactions, have enabled the efficient production of such molecules with high enantiomeric purity. These methods not only enhance synthetic efficiency but also contribute to sustainable chemistry practices by reducing waste and improving yields.
The pharmacological relevance of (1S)-1-(2,6-dichlorophenyl)ethan-1-ol stems from its potential as a precursor in the synthesis of biologically active molecules. For instance, derivatives of this compound have been explored as intermediates in the development of kinase inhibitors, which are critical in treating various cancers and inflammatory diseases. The chloro substituents on the phenyl ring can modulate electronic properties, thereby influencing receptor binding interactions.
Recent studies have highlighted the role of halogenated aromatic compounds in medicinal chemistry due to their ability to enhance metabolic stability and binding affinity. The incorporation of chlorine atoms into aromatic rings can lead to improved pharmacokinetic profiles, making (1S)-1-(2,6-dichlorophenyl)ethan-1-ol a promising scaffold for further derivatization. Researchers have leveraged computational modeling and high-throughput screening to identify novel analogs with enhanced therapeutic potential.
The synthesis of complex molecules often requires multi-step sequences that highlight the versatility of (1S)-1-(2,6-dichlorophenyl)ethan-1-ol. For example, it can serve as a precursor in constructing heterocyclic frameworks prevalent in many drugs. The presence of both an alcohol functional group and a chiral center allows for diverse chemical transformations, including esterification, oxidation, and coupling reactions. These reactions are pivotal in constructing more intricate molecular architectures essential for drug discovery.
The application of green chemistry principles has also influenced the synthesis of (1S)-1-(2,6-dichlorophenyl)ethan-1-ol. Solvent-free conditions and catalytic methods have been employed to minimize environmental impact while maintaining high yields. Such approaches align with global efforts to develop more sustainable chemical processes. Additionally, biocatalytic methods using enzymes have been explored for their ability to perform stereoselective transformations under mild conditions.
In conclusion, (1S)-1-(2,6-dichlorophenyl)ethan-1-ol represents a significant compound in modern chemical research. Its structural features make it a valuable intermediate in pharmaceutical synthesis, while its stereochemistry offers opportunities for enantioselective drug development. As research continues to advance synthetic methodologies and pharmacological understanding, compounds like this will remain at the forefront of innovation in medicinal chemistry.
225923-23-9 ((1S)-1-(2,6-dichlorophenyl)ethan-1-ol) Related Products
- 14299-54-8(Benzenemethanol,2,4,5-trichloro-a-methyl-)
- 1475-13-4(1-(2,4-Dichlorophenyl)ethanol)
- 1475-12-3(1-(2,5-Dichlorophenyl)ethanol)
- 16071-26-4(Benzenemethanol,2-chloro-a-phenyl-, (aR)-)
- 14866-28-5(1-(2,4-Dichlorophenyl)-1,2-ethanediol)
- 13524-04-4(1-(2-Chlorophenyl)ethanol)
- 53066-19-6(1-(2,6-Dichlorophenyl)ethanol)
- 131864-71-6((S)-1-(2-Chlorophenyl)ethanol)
- 120466-66-2((R)-1-(2-Chlorophenyl)ethanol)
- 586418-00-0(1,2-Ethanediol, 1-(2,4-dichlorophenyl)-, (1R)-)